BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26971243)

  • 1. Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals.
    Ferns RB; Tarr AW; Hue S; Urbanowicz RA; McClure CP; Gilson R; Ball JK; Nastouli E; Garson JA; Pillay D
    Virology; 2016 May; 492():213-24. PubMed ID: 26971243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
    Tong Y; Li Q; Li R; Xu Y; Pan Y; Niu J; Zhong J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.
    Erickson AL; Kimura Y; Igarashi S; Eichelberger J; Houghton M; Sidney J; McKinney D; Sette A; Hughes AL; Walker CM
    Immunity; 2001 Dec; 15(6):883-95. PubMed ID: 11754811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.
    Liu L; Nardo D; Li E; Wang GP
    AIDS; 2016 Mar; 30(5):691-700. PubMed ID: 26645605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
    Farci P; Shimoda A; Coiana A; Diaz G; Peddis G; Melpolder JC; Strazzera A; Chien DY; Munoz SJ; Balestrieri A; Purcell RH; Alter HJ
    Science; 2000 Apr; 288(5464):339-44. PubMed ID: 10764648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection of a neutralization-resistant hepatitis C virus escape mutant.
    Gal-Tanamy M; Keck ZY; Yi M; McKeating JA; Patel AH; Foung SK; Lemon SM
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19450-5. PubMed ID: 19052239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
    von Hahn T; Yoon JC; Alter H; Rice CM; Rehermann B; Balfe P; McKeating JA
    Gastroenterology; 2007 Feb; 132(2):667-78. PubMed ID: 17258731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
    PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
    Cusick MF; Yang M; Gill JC; Eckels DD
    Hum Immunol; 2011 May; 72(5):379-85. PubMed ID: 21377503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
    Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
    AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients.
    López-Labrador FX; Dove L; Hui CK; Phung Y; Kim M; Berenguer M; Wright TL
    Virus Res; 2007 Dec; 130(1-2):285-91. PubMed ID: 17601623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F; Eckels DD
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation
    Fauteux-Daniel S; Larouche A; Calderon V; Boulais J; Béland C; Ransy DG; Boucher M; Lamarre V; Lapointe N; Boucoiran I; Le Campion A; Soudeyns H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy.
    Vuillermoz I; Khattab E; Sablon E; Ottevaere I; Durantel D; Vieux C; Trepo C; Zoulim F
    J Med Virol; 2004 Sep; 74(1):41-53. PubMed ID: 15258967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection.
    Rodrigo C; Walker MR; Leung P; Eltahla AA; Grebely J; Dore GJ; Applegate T; Page K; Dwivedi S; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Luciani F; Lloyd AR; Bull RA;
    Infect Genet Evol; 2017 Apr; 49():88-96. PubMed ID: 28065804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
    Fafi-Kremer S; Fauvelle C; Felmlee DJ; Zeisel MB; Lepiller Q; Fofana I; Heydmann L; Stoll-Keller F; Baumert TF
    Viruses; 2012 Oct; 4(10):2016-30. PubMed ID: 23202451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection.
    Dietz J; Lutz T; Knecht G; Gute P; Berkowski C; Lange CM; Khaykin P; Stephan C; Brodt HR; Herrmann E; Zeuzem S; Sarrazin C
    Virology; 2015 Nov; 485():213-22. PubMed ID: 26295281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.